1-(2-Pyridinyl)piperazine structure
|
Common Name | 1-(2-Pyridinyl)piperazine | ||
---|---|---|---|---|
CAS Number | 34803-66-2 | Molecular Weight | 163.22 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 314.4±22.0 °C at 760 mmHg | |
Molecular Formula | C9H13N3 | Melting Point | 92-94 | |
MSDS | Chinese USA | Flash Point | 143.9±22.3 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of 1-(2-Pyridinyl)piperazine1-(2-Pyridyl)piperazine is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
Name | 1-pyridin-2-ylpiperazine |
---|---|
Synonym | More Synonyms |
Description | 1-(2-Pyridyl)piperazine is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
---|---|
Related Catalog | |
In Vitro | 1-(2-Pyridyl)piperazine 是一种选择性的 α2-肾上腺素能受体拮抗剂。它显示出同情活动。它也是 Azaperone 的代谢产物。 |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 314.4±22.0 °C at 760 mmHg |
Melting Point | 92-94 |
Molecular Formula | C9H13N3 |
Molecular Weight | 163.22 |
Flash Point | 143.9±22.3 °C |
Exact Mass | 163.110947 |
PSA | 28.16000 |
LogP | 0.19 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.547 |
Storage condition | Flammables area |
Water Solubility | >500 g/L (20 ºC) |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
Hazard Codes | Xi:Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36 |
RIDADR | 2735 |
WGK Germany | 3 |
Packaging Group | II |
Hazard Class | 8 |
HS Code | 2933990090 |
~54% 1-(2-Pyridinyl)... CAS#:34803-66-2 |
Literature: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; CHEMON INC. Patent: WO2008/153325 A1, 2008 ; Location in patent: Page/Page column 43 ; |
~97% 1-(2-Pyridinyl)... CAS#:34803-66-2 |
Literature: BIOENERGENIX; MCCALL, John, M.; MCKEARN, John; ROMERO, Donnal, L.; CLAIR, Michael Patent: WO2011/28947 A2, 2011 ; Location in patent: Page/Page column 50; 51 ; WO 2011/028947 A1 |
~77% 1-(2-Pyridinyl)... CAS#:34803-66-2 |
Literature: Brenner, Eric; Schneider, Raphael; Fort, Yves Tetrahedron Letters, 2000 , vol. 41, # 16 p. 2881 - 2884 |
~76% 1-(2-Pyridinyl)... CAS#:34803-66-2 |
Literature: Tetrahedron, , vol. 58, # 34 p. 6913 - 6924 |
~91% 1-(2-Pyridinyl)... CAS#:34803-66-2 |
Literature: Brenner, Eric; Schneider, Raphael; Fort, Yves Tetrahedron, 1999 , vol. 55, # 44 p. 12829 - 12842 |
~% 1-(2-Pyridinyl)... CAS#:34803-66-2 |
Literature: Tetrahedron, , vol. 55, # 44 p. 12829 - 12842 |
~% 1-(2-Pyridinyl)... CAS#:34803-66-2 |
Literature: Journal of Organic Chemistry, , vol. 18, p. 1484,1487 |
Precursor 5 | |
---|---|
DownStream 10 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Pharmacological evidence for the involvement of 1-(2-pyridinyl)-piperazine (1-PmP) in the interaction of buspirone or gepirone with noradrenergic systems.
Eur. J. Pharmacol. 134(1) , 113-6, (1987) We investigated in mice the effects of one of the principal metabolites of buspirone and gepirone, 1-(2-pyridinyl)-piperazine (1-PmP), on hypothermia and reduced locomotion induced by clonidine (0.25 ... |
|
6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats.
Drug Metab. Dispos. 35(8) , 1387-92, (2007) The pharmacokinetics and in vivo potency of 6-hydroxybuspirone (6-OH-buspirone), a major metabolite of buspirone, were investigated. The plasma clearance (47.3 +/- 3.5 ml/min/kg), volume of distributi... |
|
New lithocholic and chenodeoxycholic piperazinylcarboxamides with antiproliferative and pro-apoptotic effects on human cancer cell lines.
Bioorg. Med. Chem. 16 , 8737-44, (2008) Six new synthetic bile acid derivatives were synthesized and tested in vitro against various human cancer cells (glioblastoma multiforme (GBM), multiple myeloma (KMS-11), and colonic carcinoma (HCT-11... |
2-(1-Piperazinyl)pyridine |
1-(pyridin-2-yl)piperazine |
2-Piperazinopyridine |
1-(2-Pyridinyl)piperazine |
Piperazine, 1-(2-pyridinyl)- |
MFCD00006216 |
EINECS 252-220-3 |
2-pyridylpiperazine |
1-(2-Pyridyl)Piperazine |